Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus (Q41655898)

6 October 2017

title

Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus (English)

1 reference

6 October 2017

8

1 reference

6 October 2017

Sandrine Henri

7

0 references

Even Fossum

object named as

Even Fossum

1

0 references

Bjarne Bogen

9

object named as

Bjarne Bogen

1 reference

6 October 2017

Gunnveig Grødeland

2

1 reference

6 October 2017

Dorothea Terhorst

3

1 reference

6 October 2017

Anders A Tveita

4

1 reference

6 October 2017

Elisabeth Vikse

5

1 reference

6 October 2017

Siri Mjaaland

6

1 reference

6 October 2017

language of work or name

English

0 references

publication date

28 December 2014

1 reference

European Journal of Immunology

6 October 2017

published in

1 reference

6 October 2017

volume

45

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

624-635

1 reference

Introduction of soluble protein into the class I pathway of antigen processing and presentation

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Antibody-targeted vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Monomeric solution structure of the prototypical 'C' chemokine lymphotactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Evolution of B cell responses to Clec9A-targeted antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

The JAM test. A simple assay for DNA fragmentation and cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201445080

7 January 2021

Identifiers

DOI

10.1002/EJI.201445080

1 reference

6 October 2017

1 reference